Results 31 to 40 of about 181,406 (245)

Use of granulocyte colony-stimulating factor for treatment of aplastic anemia [PDF]

, 1999
1999-11Over the last ten years, recombinant human granulocyte colony-stimulating factor (rh G-CSF) has been widely used in the treatment of aplastic anemia (AA).
Kojima, Seiji
core   +1 more source

Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study

Haematologica, 2009
Background Associations between aplastic anemia and numerous drugs, pesticides and chemicals have been reported. However, at least 50% of the etiology of aplastic anemia remains unexplained.Design and Methods This was a case-control, multicenter ...
Eliane Maluf, Nelson Hamerschlak, Alexandre Biasi Cavalcanti, Álvaro Avezum Júnior, José Eluf-Neto, Roberto Passetto Falcão, Irene G. Lorand-Metze, Daniel Goldenberg, Cézar Leite Santana, Daniela de Oliveira Werneck Rodrigues, Leny Nascimento da Motta Passos, Luis Gastão Mange Rosenfeld, Marimilia Pitta, Sandra Loggetto, Andreza A. Feitosa Ribeiro, Elvira Deolinda Velloso, Andrea Tiemi Kondo, Erika Oliveira de Miranda Coelho, Maria Carolina Tostes Pintão, Hélio Moraes de Souza, José Rafael Borbolla, Ricardo Pasquini   +21 more
doaj   +1 more source

Aplastic Anemia in a Developing Country: The Present and the Need [PDF]

National Journal of Laboratory Medicine, 2016
Introduction: Aplastic anemia (AA) a rare, yet a life threatening hematological disorder. Aplastic anemia if untreated results in very high mortality. Early diagnosis of Aplastic anemias is essential for appropriate management of the patient.
Ashwini BR , Seetu Palo, Siddiq M Ahmed
doaj   +1 more source

Aplastic Anemia in Pregnancy [PDF]

The Journal of Obstetrics and Gynecology of India, 2013
Although aplastic anemia was first recognized by Ehrlich in 1888, the pathogenesis of aplastic anemia has remained elusive. The prevalence of aplastic anemia in pregnancy is rare. Aplastic anemia is a subtype of anemia characterized by pancytopenia and a hypocellular bone marrow.
Swati, Rathore, Angsumita, Pramanick, Annie, Regi, Jessie, Lionel   +3 more
openaire   +2 more sources

Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis

Medical Mycology Case Reports, 2019
Severe aplastic anemia (SAA) is a hematological disease resulting in pancytopenia due to bone marrow failure. Treatment consists of immunosppressive therapy, or allo-SCT.
Jean El-Cheikh, Ali Atoui, Nour Moukalled, Nohra Ghaoui, Haidar El Darsa, Souha S. Kanj, Ali Bazarbachi   +6 more
doaj   +1 more source

Time Series Analysis of Age-Sex Specific Death Rates from Aplastic Anemia and the Trend in Production Amount of Chloramphenicol [PDF]

, 1982
1982-03To explore the epidemiological features of aplastic anemia, the mortality statistics (1958-1978) in Japan were examined by age and sex. Mortality trends by age were fitted by the regression curves derived from Akaike Information Criteria Method ...
MIZUNO, SHOICHI, OHNO, YOSHIYUKI, HAMAJIMA, NOBUYUKI, AOKI, KUNIO, SASAKI, RYUICHIRO   +4 more
core   +1 more source

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity

Asian Journal of Transfusion Science, 2015
Background: Thrombopoietin (TPO) is the key hematopoietic growth factor regulating the production of platelets from bone marrow megakaryocytes and maintaining platelet hemostasis.
Abhay Singh, Anupam Verma, Soniya Nityanand, Rajendra Chaudhary, Priti Elhence   +4 more
doaj   +1 more source

Proposed protocol for treatment of severe periodontitis without platelet transfusion in patients with aplastic anemia: a case report

Journal of Medical Case Reports, 2021
Background Aplastic anemia is an intractable disease characterized by pancytopenia, susceptibility to infection, and difficulty in achieving hemostasis.
Satoru Morikawa, Kazuya Watanabe, Satoshi Usuda, Yoko Miyashita, Taneaki Nakagawa   +4 more
doaj   +1 more source

Latin American Collaborative Research on Aplastic Anemia (LARAA): creating a regional registry [PDF]

, 2021
Aplastic anemia (AA) is a rare but serious disease that affects hematopoietic stem cells and is characterized by pancytopenia and a hypocellular bone marrow. It can be a hereditary or acquired condition.
Navarro, Juan Ramón, Pardo, Carlos Alberto, López, Stefanía, Calado, Rodrigo T., Milovic, Vera, Beligoy, Luis, López, José Luis, Vidal-Senmache, Gabriela, Rojas, Christine, Gabus, Raúl, Aranguiz, Natalia, Tokumura, Carolina, Abello, Virginia, LaTorre-Matuk, Alejandra, Sossa, Claudia Lucía, Fanti, Dorotea, Mendoza, Carlos   +16 more
core  

A plasma microRNA signature as a biomarker for acquired aplastic anemia

Haematologica, 2017
Aplastic anemia is an acquired bone marrow failure characterized by marrow hypoplasia, a paucity of hematopoietic stem and progenitor cells, and pancytopenia of the peripheral blood, due to immune attack on the bone marrow.
Kohei Hosokawa, Sachiko Kajigaya, Xingmin Feng, Marie J. Desierto, Maria del Pilar Fernandez Ibanez, Olga Rios, Barbara Weinstein, Phillip Scheinberg, Danielle M. Townsley, Neal S. Young   +9 more
doaj   +1 more source